Dosimetry, Safety and Potential Benefit of 177Lu-PSMA-617 Prior to Prostatectomy (LuTectomy)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04430192 |
|
Recruitment Status :
Active, not recruiting
First Posted : June 12, 2020
Last Update Posted : May 10, 2022
|
Sponsor:
Peter MacCallum Cancer Centre, Australia
Collaborators:
Movember Foundation
Medical Research Future Fund
Endocyte
E.J. Whitten Foundation Prostate Cancer Research Centre
Information provided by (Responsible Party):
Peter MacCallum Cancer Centre, Australia
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Estimated Primary Completion Date : | August 7, 2022 |
| Estimated Study Completion Date : | June 30, 2023 |